Alerts will be sent to your verified email
Verify Email
ABBOTINDIA
|
Abbott India
|
Alkem Laboratories
|
Aurobindo Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
30.11 % | 17.38 % | 12.72 % |
|
5yr Avg Net Profit Margin
|
18.53 % | 14.54 % | 12.5 % |
|
Price to Book
|
16.1 | 5.29 | 1.82 |
|
P/E
|
46.93 | 27.73 | 17.56 |
|
5yr Avg Cash Conversion Cycle
|
-46.68 Days | -61.46 Days | -46.37 Days |
|
5yr Average Interest Coverage Ratio
|
97.37 | 24.48 | 43.54 |
|
5yr Avg ROCE
|
38.77 % | 22.76 % | 15.27 % |
|
5yr Avg Operating Profit Margin
|
23.42 % | 18.44 % | 19.22 % |
|
5 yr average Debt to Equity
|
0.0 | 0.18 | 0.19 |
|
5yr CAGR Net Profit
|
15.41 % | 6.44 % | -8.16 % |
|
5yr Average Return on Assets
|
21.03 % | 12.47 % | 8.64 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
74.99 % | 53.04 % | 51.82 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 17.08 % |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -4.1 % | -0.01 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
2.93 % | 8.82 % | 9.14 % |
|
Abbott India
|
Alkem Laboratories
|
Aurobindo Pharma
|
|---|